A favorable risk-benefit analysis of high dose thyroid for treatment of bipolar disorders with regard to osteoporosis

Journal of Affective Disorders

Volumn 166, Issue , 2014, Pages 353-358

  Kelly, Tammas ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Bipolar I; Bipolar II; High dose thyroid; Osteoporosis; Risk benefit; Treatment

Indexed keywords

THYROID HORMONE;

BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; DRUG MEGADOSE; ENDOCRINOLOGY; HUMAN; INFORMATION RETRIEVAL; MOOD DISORDER; MORBIDITY; MORTALITY; OSTEOPOROSIS; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHIATRY; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; CHEMICALLY INDUCED; COMPLICATION; DOSE RESPONSE; RISK;

BIPOLAR DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; OSTEOPOROSIS; RISK; THYROID HORMONES;

EID: 84903575790     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2014.04.022     Document Type: Review

References (56)

1. Guide to 2012. The Annual Meeeting. The American Psychiatric Association's 2012 Annual Meeting, 2012.
2. Guide to 2013. The Annual Meeeting. The American Psychiatric Association's 2013 Annual Meeting, 2013.
3. Thomas T. Aoki, Eugen O. Grecu, Prashante R. Srinivas, Pamela Prescott, Mahmoud M. Benbarka, and Michael A. Arcangeli Prevalence of osteoporosis in women: variation with skeletal site of measurement of bone mineral density Endocr. Pract. 6 2000 127 131
4. R.S. Bahn, H.B. Burch, D.S. Cooper, J.R. Garber, M.C. Greenlee, I. Klein, P. Laurberg, I.R. Mcdougall, V.M. Montori, and S.A. Rivkees Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists Thyroid 21 2011 593 646
5. L. Bartalena, L. Pellegrini, M. Meschi, L. Antonangeli, F. Bogazzi, L. Dell'osso, A. Pinchera, and G.F. Placidi Evaluation of thyroid function in patients with rapid-cycling and non-rapid-cycling bipolar disorder Psychiatry Res. 34 1990 13 17
6. M. Bauer, M. Adli, T. Bschor, A. Heinz, N. Rasgon, M. Frye, H. Grunze, R. Kupka, and P. Whybrow Clinical applications of levothyroxine in refractory mood disorders Clin. Appl. Bipolar Disord. 2 2003 49 56
7. M. Bauer, H. Baur, A. Berghöfer, A. Ströhle, R. Hellweg, B. Müller-Oerlinghausen, and A. Baumgartner Effects of supraphysiological thyroxine administration in healthy controls and patients with depressive disorders J. Affect. Disord. 68 2002 285 294
8. M. Bauer, L. Fairbanks, A. Berghöfer, J. Hierholzer, T. Bschor, C. Baethge, N. Rasgon, J. Sasse, and P.C. Whybrow Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study J. Affect. Disord. 83 2004 183 190
9. M. Bauer, E. London, N. Rasgon, S. Berman, M. Frye, L. Altshuler, M. Mandelkern, J. Bramen, B. Voytek, and R. Woods Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression Mol. Psychiatry 10 2005 456 469
10. M. Bauer, and P.C. Whybrow Thyroid hormone, neural tissue and mood modulation World J. Biol. Psychiatry 2 2001 59 69
11. M.S. Bauer, and P.C. Whybrow Rapid cycling bipolar affective disorder: II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study Arch. Gen. Psychiatry 47 1990 435
12. Z.E. Belaya, G.A. Melnichenko, L.Y. Rozhinskaya, V.V. Fadeev, T.M. Alekseeva, O.K. Dorofeeva, N.I. Sasonova, and G.S. Kolesnikova Subclinical hyperthyroidism of variable etiology and its influence on bone in postmenopausal women Hormones 6 2007 62
13. S. Chakrabarti Thyroid functions and bipolar affective disorder J. Thyroid Res. 2011 2011 306367
14. K.D. Chang, P.E. Keck Jr., S.P. Stanton, S.L. Mcelroy, S.M. Strakowski, and T.D. Geracioti Jr Differences in thyroid function between bipolar manic and mixed states Biol. Psychiatry 43 1998 730 733
15. D.P. Cole, M.E. Thase, A.G. Mallinger, J.C. Soares, J.F. Luther, D.J. Kupfer, and E. Frank Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function Am. J. Psychiatry 159 2002 116 121
16. D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. Mciver, F. Pacini, and M. Schlumberger Revised american thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer Thyroid 19 2009 1167 1214
17. R.W. Cowdry, T.A. Wehr, A.P. Zis, and F.K. Goodwin Thyroid abnormalities associated with rapid-cycling bipolar illness Arch. Gen. Psychiatry 40 1983 414
18. Crismon, M.L., Argo, T.R., Bendele, S.D., Suppes, T., 2007. Texas medication algorithm project procedural manual, Bipolar Disorder Algorithms. Texas Department of State Health Services, 〈 http://www.google.com/url?sa= t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CCcQFjAA&url= http%3A%2F%2Fwww.cardinalinnovations.org%2Fdocs%2FTIMABDman2007.pdf&ei= 5Ap-U5-uCIGPqAa6yoHYDw&usg=AFQjCNEep7FmAmg9SkP1db3qnhmEKkAZyw&sig2= 3pYm9VL9qynLZTdrTEoPswÅ 〉.
19. D.W. Dempster Osteoporosis and the burden of osteoporosis-related fractures Am. J. Manag. Care 17 2011 S164 S169
20. S.J. Diem, T.L. Blackwell, K.L. Stone, K. Yaffe, E.M. Haney, M.M. Bliziotes, and K.E. Ensrud Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures Arch. Intern. Med. 167 2007 1240
21. M. Eftekhari, A. Asadollahi, D. Beiki, S. Izadyar, A. Gholamrezanezhad, M. Assadi, A. Fard-Esfahani, B. Fallahi, A. Takavar, and M. Saghari The long term effect of levothyroxine on bone mineral density in patients with well differentiated thyroid carcinoma after treatment Hell. J. Nucl. Med. 11 2008 160 163
22. M.A. Frye, K. Ha, S. Kanba, T. Kato, A. Özerdem, G. Vázquez, and E. Vieta International consensus group on depression prevention in bipolar disorder J. Clin. Psychiatry 72 2011 1295
23. L. Gyulai, M. Bauer, F. Garcia-Espana, J. Hierholzer, A. Baumgartner, A. Berghöfer, and P.C. Whybrow Bone mineral density in pre-and post-menopausal women with affective disorder treated with long-term l-thyroxine augmentation J. Affect. Disord. 66 2001 185 191
24. L. Gyulai, J. Jaggi, M.S. Bauer, S. Younkin, L. Rubin, M. Attie, and P.C. Whybrow Bone mineral density and l-thyroxine treatment in rapidly cycling bipolar disorder Biol. Psychiatry 41 1997 503 506
25. U. Halbreich, N. Rojansky, S. Palter, M. Hreshchyshyn, J. Kreeger, Y. Bakhai, and R. Rosan Decreased bone mineral density in medicated psychiatric patients Psychosom. Med. 57 1995 485 491
26. K. Heemstra, N. Hamdy, J. Romijn, and J. Smit The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinoma Thyroid 16 2006 583 591
27. Hirschfeld, R.M.A., 2002. Practice Guideline for the Treatment of Patients With Bipolar Disorder, 2nd edition [Online]. American Psychiatric Association. Available: 〈http://psychiatryonline.org/content.aspx?bookid= 28§ionid=1682557〉.
28. T. Kelly, L. Douglas, L. Denmark, G. Brasuell, and D.Z. Lieberman The high prevalence of obstructive sleep apnea among patients with bipolar disorders J. Affect. Disord. 2013
29. T. Kelly, and D.Z. Lieberman The use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar disorder NOS J. Affect. Disord. 116 2009 222 226
30. A. Kung, and S. Yeung Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin J. Clin. Endocrinol. Metab. 81 1996 1232 1236
31. P. Lakatos Thyroid hormones: beneficial or deleterious for bone? Calcif. Tissue Int. 73 2003 205 209
32. P. Magalhaes, F. Kapczinski, A. Nierenberg, T. Deckersbach, D. Weisinger, S. Dodd, and M. Berk Illness burden and medical comorbidity in the systematic treatment enhancement program for bipolar disorder Acta Psychiatrica Scand. 125 2012 303 308
33. K.M. Mangano, S.J. Walsh, K.L. Insogna, A.M. Kenny, and J.E. Kerstetter Calcium intake in the United States from dietary and supplemental sources across adult age groups: new estimates from the National Health and Nutrition Examination Survey 2003-2006 J. Am. Diet. Assoc. 111 2011 687 695
34. A.R. Mansourian A review on hyperthyroidism: thyrotoxicosis under surveillance Pak. J. Biol. Sci. 13 2010 1066
35. M.B. O'Connell, L.M. Borgelt, S.K. Bowles, and S.F. Vondracek Drug-induced osteoporosis in the older adult Aging Health 6 2010 501 518
36. H. Oomen, A. Schipperijn, and H. Drexhage The prevalence of affective disorder and in particular of a rapid cycling of bipolar disorder in patients with abnormal thyroid function tests Clin. Endocrinol. 45 1996 215 223
37. U. Osby, L. Brandt, N. Correia, A. Ekbom, and P. Sparen Excess mortality in bipolar and unipolar disorder in Sweden Arch. Gen. Psychiatry 58 2001 844
38. Package-Insert. 2014a. Drug Lable CYTOMEL (liothyronine sodium) tablet [King Pharmaceuticals, Inc.] [Online]. National Library of Medicine (US). Available: 〈http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=51452b31- ff68-4e0c-b982-c15502ebf1d3〉.
39. Package-Insert. 2014b. Drug Lable SYNTHROID (levothyroxine sodium) tablet [AbbVie Inc.] [Online]. National Library of Medicine (US). Available: 〈http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1e11ad30-1041-4520- 10b0-8f9d30d30fcc〉.
40. A.N. Peiris, E. Oh, and S. Diaz Psychiatric manifestations of thyroid disease South. Med. J. 100 2007 773 774
41. Quan, M.L., Pasieka, J.L. & Rorstad, O. 2002. Bone mineral density in well-differentiated thyroid cancer patients treated with suppressive thyroxine: a systematic overview of the literature. J. Surg. Oncol., 79, 62-9; discussion 69-70.
42. W.A. Ray, S. Meredith, P.B. Thapa, K.G. Meador, K. Hall, and K.T. Murray Antipsychotics and the risk of sudden cardiac death Arch. Gen. Psychiatry 58 2001 1161
43. R. Ricken, F. Bermpohl, P. Schlattmann, T. Bschor, M. Adli, N. Mönter, and M. Bauer Long-term treatment with supraphysiological doses of thyroid hormone in affective disorders - effects on bone mineral density J. Affect. Disord. 136 2012 e89 e94
44. L.J. Rosenthal, W.S. Goldner, and J.P. O'reardon T3 augmentation in major depressive disorder: safety considerations Am. J. Psychiatry 168 2011 1035 1040
45. M. Rylander, and S. Verhulst Vitamin D insufficiency in psychiatric inpatients J. Psychiatr. Pract. 19 2013 296 300
46. G.S. Sachs, D.J. Printz, D.A. Kahn, D. Carpenter, and J.P. Docherty The expert consensus guideline series: medication treatment of bipolar disorder Postgrad. Med. 1 2000 1 104
47. G. Schett, and J.-P. David The multiple faces of autoimmune-mediated bone loss Nat. Rev. Endocrinol. 6 2010 698 706
48. I. Sugitani, and Y. Fujimoto Effect of postoperative thyrotropin suppressive therapy on bone mineral density in patients with papillary thyroid carcinoma: a prospective controlled study Surgery 150 2011 1250 1257
49. B.M. Tang, G.D. Eslick, C. Nowson, C. Smith, and A. Bensoussan Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis Lancet 370 2007 657 666
50. D.J. Topliss, and C.J. Eastman Diagnosis and management of hyperthyroidism and hypothyroidism Medical journal of Australia 180 2004 186 194
51. P. Vestergaard Skeletal effects of central nervous system active drugs: anxiolytics, sedatives, antidepressants, lithium and neuroleptics Curr. Drug Saf. 3 2008 185 189
52. J.R. Wall, and H. Lahooti Pathogenesis of thyroid eye disease - does autoimmunity against the TSH receptor explain all cases Endokrynol. Pol. 61 2010 222 227
53. J.C. Woolcott, K.J. Richardson, M.O. Wiens, B. Patel, J. Marin, K.M. Khan, and C.A. Marra Meta-analysis of the impact of 9 medication classes on falls in elderly personsmedications and falls in elderly persons Arch. Intern. Med. 169 2009 1952 1960
54. L.N. Yatham, S.H. Kennedy, S.V. Parikh, A. Schaffer, S. Beaulieu, M. Alda, C. O'donovan, G. Macqueen, R.S. Mcintyre, V. Sharma, A. Ravindran, L.T. Young, R. Milev, D.J. Bond, B.N. Frey, B.I. Goldstein, B. Lafer, B. Birmaher, K. Ha, W.A. Nolen, and M. Berk Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013 Bipolar Disord. 15 2013 1 44
55. L.N. Yatham, S.H. Kennedy, A. Schaffer, S.V. Parikh, S. Beaulieu, C. O'donovan, G. Macqueen, R.S. Mcintyre, V. Sharma, A. Ravindran, L.T. Young, A.H. Young, M. Alda, R. Milev, E. Vieta, J.R. Calabrese, M. Berk, K. Ha, and F. Kapczinski Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009 Bipolar Disord. 11 2009 225 255
56. A. Zamani, G.R. Omrani, and M.M. Nasab Lithium's effect on bone mineral density Bone 44 2009 331 334